Mediclinic International PLC
LSE:MDC
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
UK |
Mediclinic International PLC
LSE:MDC
|
3.7B GBP | 1.1 | ||
US |
HCA Healthcare Inc
NYSE:HCA
|
86.5B USD | 1.3 | ||
SA |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
101.4B SAR | 10.4 | ||
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
116.6B CNY | 6.1 | |
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
15.6B Zac | 0 | |
ZA |
N
|
Netcare Ltd
JSE:NTC
|
15.1B Zac | 0 | |
BR |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
69.8B BRL | 1.5 | ||
US |
Tenet Healthcare Corp
NYSE:THC
|
13B USD | 0.6 | ||
TH |
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
460.9B THB | 4.6 | |
US |
Universal Health Services Inc
NYSE:UHS
|
12.2B USD | 0.8 | ||
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
54.9B MYR | 2.6 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.